Surgical emergencies in the cancer patient. ([2016])
- Record Type:
- Book
- Title:
- Surgical emergencies in the cancer patient. ([2016])
- Main Title:
- Surgical emergencies in the cancer patient
- Further Information:
- Note: Yuman Fong, Rondi Marie Kauffmann, Emily Marcinkowski, Gagandeep Singh, Hans F. Schoellhammer, editors.
- Editors:
- Fong, Yuman
Kauffmann, Rondi Marie
Marcinkowski, Emily
MD, Singh, Gagandeep
Schoellhammer, Hans F - Contents:
- Preface; Foreword; Contents; Contributors; 1: Preoperative Evaluation of the Cancer Patient for Emergency Surgery; Introduction; The American Society of Anesthesiologists' Risk Classification; Preoperative Cardiovascular Risk Assessment; Coronary Artery Disease; Heart Failure; Valvular Heart Disease; Aortic Stenosis; Mitral Stenosis; Aortic Regurgitation and Mitral Regurgitation; Perioperative Fluid Management; Transfusions; Sepsis; Preoperative Pulmonary Evaluation; Airway Management; References; 2: Toxicity of Antineoplastic Therapy and Considerations for Perioperative Care Introduction Cytotoxic Agents and Potential Organ Toxicity; Hematologic Toxicity; Cardiac Toxicity; Anthracycline Antitumor Antibiotics; Alkylating Agents; Other Chemotherapeutic Agents with Potential Cardiotoxicity; Pulmonary Toxicity; Antitumor Antibiotics; Renal Toxicity; Platinum Agents; Neurologic Toxicity; Hepatic Toxicity; Specific Considerations in Perioperative Care; Corticosteroids; Agents with Anti-angiogenic Activity; Toxicity of Specific Chemotherapy Regimens; Hyperthermic Intraoperative Intraperitoneal Chemotherapy Early Postoperative Intraperitoneal Chemotherapy (EPOCH or EPIC) Summary; References; 3: Surgical Considerations and Emergencies in the Cancer Patient Receiving Immunotherapy; Introduction; Current Progress of Immunotherapy in Cancer; Overview of Immune Checkpoint Pathways; CTLA4 Axis; PD-1 Axis; Future Pathways of Interest; Current Immune Checkpoint Inhibitors Approved and inPreface; Foreword; Contents; Contributors; 1: Preoperative Evaluation of the Cancer Patient for Emergency Surgery; Introduction; The American Society of Anesthesiologists' Risk Classification; Preoperative Cardiovascular Risk Assessment; Coronary Artery Disease; Heart Failure; Valvular Heart Disease; Aortic Stenosis; Mitral Stenosis; Aortic Regurgitation and Mitral Regurgitation; Perioperative Fluid Management; Transfusions; Sepsis; Preoperative Pulmonary Evaluation; Airway Management; References; 2: Toxicity of Antineoplastic Therapy and Considerations for Perioperative Care Introduction Cytotoxic Agents and Potential Organ Toxicity; Hematologic Toxicity; Cardiac Toxicity; Anthracycline Antitumor Antibiotics; Alkylating Agents; Other Chemotherapeutic Agents with Potential Cardiotoxicity; Pulmonary Toxicity; Antitumor Antibiotics; Renal Toxicity; Platinum Agents; Neurologic Toxicity; Hepatic Toxicity; Specific Considerations in Perioperative Care; Corticosteroids; Agents with Anti-angiogenic Activity; Toxicity of Specific Chemotherapy Regimens; Hyperthermic Intraoperative Intraperitoneal Chemotherapy Early Postoperative Intraperitoneal Chemotherapy (EPOCH or EPIC) Summary; References; 3: Surgical Considerations and Emergencies in the Cancer Patient Receiving Immunotherapy; Introduction; Current Progress of Immunotherapy in Cancer; Overview of Immune Checkpoint Pathways; CTLA4 Axis; PD-1 Axis; Future Pathways of Interest; Current Immune Checkpoint Inhibitors Approved and in Development (Table 3.1); Ipilimumab; Tremelimumab; Nivolumab; Pembrolizumab; MEDI4736; BMS-936559; MPDL3280A; Gastrointestinal Toxicities from Immunotherapy (Table 3.2); CTLA4 Inhibitors PD-1/PD-L1 Inhibitors Combining CTLA4 and PD-1/PD-L1 Inhibitors; Therapeutic Strategies for Treatment of Immunotherapy-Induced Colitis; Conclusions; References; 4: Surgery in the Thrombocytopenic and Coagulopathic Patient; Introduction; Background; Thrombocytopenia; Inherited Coagulopathies; Perioperative Acquired Coagulopathy; Therapeutic Anticoagulation; Warfarin; Unfractionated Heparin; Low-Molecular-Weight Heparins; Fondaparinux; Direct Xa Inhibitors; Direct Thrombin Inhibitors; Hemostatic Agents and Devices; Current Recommendations for Transfusions Cancer Outcomes After Transfusions Implications of the Spleen in Regulation of Thrombocyte Counts and Spleen-Based Regulation of the Immune System; Summary; References; 5: Emergency Surgery After Previous Radiation Therapy; Identifying a Previously Irradiated Patient; Radiation Therapy Terminology; Basics of Radiation Exposure, Dose, and Types; Radiation Techniques and Terminology; Biology of Radiation Exposure of Normal Tissues; Skin; Mucosa; Muscles; Lymphatics; Evaluating the Previously Irradiated Patient for Consideration of Surgery; Overall Status of the Patient … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2016
- Copyright Date:
- 2017
- Extent:
- 1 online resource
- Subjects:
- 616.99/405
610
Medicine
Cancer -- Surgery
Surgical emergencies
Cancer -- Surgery
Surgical emergencies
HEALTH & FITNESS / Diseases / General
MEDICAL / Clinical Medicine
MEDICAL / Diseases
MEDICAL / Evidence-Based Medicine
MEDICAL / Internal Medicine
Medical -- Surgery -- General
Medical -- Oncology
Surgical oncology
Oncology
Surgery
Surgical oncology
Oncology
General surgery
Electronic books - Languages:
- English
- ISBNs:
- 9783319440255
- Related ISBNs:
- 331944025X
9783319440231 - Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from PDF title page (SpringerLink, viewed December 7, 2016). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.363741
- Ingest File:
- 01_332.xml